RS
The startup has developed an artificial intelligence-based optical detection system that provides real-time tissue diagnostics for cancer treatment. This technology enhances tumor margin assessment and tissue characterization, enabling surgeons to make more informed decisions during procedures.
Updated 3 months ago
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed an artificial intelligence-based optical detection system that provides real-time tissue diagnostics for cancer treatment. This technology enhances tumor margin assessment and tissue characterization, enabling surgeons to make more informed decisions during procedures.